These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32627373)

  • 1. Efficient Inhibition of Wear-Debris-Induced Osteolysis by Surface Biomimetic Engineering of Titanium Implant with a Mussel-Derived Integrin-Targeting Peptide.
    Guo X; Liu Y; Bai J; Yu B; Xu M; Sun H; Shen J; Lin J; Zhang H; Wang D; Geng D; Pan G
    Adv Biosyst; 2019 Feb; 3(2):e1800253. PubMed ID: 32627373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
    Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
    Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amentoflavone Inhibits Osteoclastogenesis and Wear Debris-Induced Osteolysis via Suppressing NF-κB and MAPKs Signaling Pathways.
    Zhang Z; Zhao S; Li X; Zhuo X; Zhang W; Nie Q; Wang S; Yan L; Sun Y
    Planta Med; 2018 Jul; 84(11):759-767. PubMed ID: 29301147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model.
    Xiao F; Zhai Z; Jiang C; Liu X; Li H; Qu X; Ouyang Z; Fan Q; Tang T; Qin A; Gu D
    Exp Cell Res; 2015 Jan; 330(1):91-101. PubMed ID: 25016282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.
    Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D
    Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentamidine Inhibits Titanium Particle-Induced Osteolysis
    Ihn HJ; Kim K; Cho HS; Park EK
    Tissue Eng Regen Med; 2019 Jun; 16(3):265-273. PubMed ID: 31205855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-106b inhibition suppresses inflammatory bone destruction of wear debris-induced periprosthetic osteolysis in rats.
    Yu B; Bai J; Shi J; Shen J; Guo X; Liu Y; Ge G; Lin J; Tao Y; Yang H; Xu Y; Qu Q; Geng D
    J Cell Mol Med; 2020 Jul; 24(13):7490-7503. PubMed ID: 32485091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progranulin suppresses titanium particle induced inflammatory osteolysis by targeting TNFα signaling.
    Zhao YP; Wei JL; Tian QY; Liu AT; Yi YS; Einhorn TA; Liu CJ
    Sci Rep; 2016 Feb; 6():20909. PubMed ID: 26864916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal implant debris-induced osteolysis.
    Hallab NJ; Cunningham BW; Jacobs JJ
    Spine (Phila Pa 1976); 2003 Oct; 28(20):S125-38. PubMed ID: 14560184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin inhibits osteoclast formation and wear-debris-induced bone destruction by suppressing mitogen-activated protein kinases.
    Shi J; Wang Z; Guo X; Shen J; Sun H; Bai J; Yu B; Wang L; Zhou W; Liu Y; Zhang W; Yang H; Xu Y; Zhou J; Geng D
    J Cell Physiol; 2020 Mar; 235(3):2599-2608. PubMed ID: 31498438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model.
    Chen D; Zhang X; Guo Y; Shi S; Mao X; Pan X; Cheng T
    Int J Mol Med; 2012 Dec; 30(6):1417-23. PubMed ID: 23027468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro.
    Wu C; Wang W; Tian B; Liu X; Qu X; Zhai Z; Li H; Liu F; Fan Q; Tang T; Qin A; Zhu Z
    Biochem Pharmacol; 2015 Jan; 93(1):59-71. PubMed ID: 25449599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scutellarin inhibits RANKL-mediated osteoclastogenesis and titanium particle-induced osteolysis via suppression of NF-κB and MAPK signaling pathway.
    Zhao S; Sun Y; Li X; Wang J; Yan L; Zhang Z; Wang D; Dai J; He J; Wang S
    Int Immunopharmacol; 2016 Nov; 40():458-465. PubMed ID: 27728897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11R-VIVIT Peptide Inhibits Calvaria Osteolysis Induced by Experimental Design.
    Li M; Zhu L; Wang X; Bian Z; Yao W; He Q; Tian F
    J Craniofac Surg; 2017 Mar; 28(2):570-573. PubMed ID: 28114216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation.
    Wang C; Liu Y; Wang Y; Li H; Zhang RX; He MS; Chen L; Wu NN; Liao Y; Deng ZL
    Med Sci Monit; 2016 Mar; 22():727-35. PubMed ID: 26939934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis.
    Childs LM; Paschalis EP; Xing L; Dougall WC; Anderson D; Boskey AL; Puzas JE; Rosier RN; O'Keefe RJ; Boyce BF; Schwarz EM
    J Bone Miner Res; 2002 Feb; 17(2):192-9. PubMed ID: 11811549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampin suppresses osteoclastogenesis and titanium particle-induced osteolysis via modulating RANKL signaling pathways.
    Zhu L; Kang H; Guo CA; Fan WS; Wang YM; Deng LF; Yan ZQ
    Biochem Biophys Res Commun; 2017 Feb; 484(1):64-70. PubMed ID: 28108285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.
    Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM
    J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arctigenin inhibits RANKL-induced osteoclastogenesis and hydroxyapatite resorption in vitro and prevents titanium particle-induced bone loss in vivo.
    Wei G; Liang T; Wei C; Nong X; Lu Q; Zhao J
    J Cell Biochem; 2019 Apr; 120(4):5367-5376. PubMed ID: 30317692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis.
    Goater JJ; O'Keefe RJ; Rosier RN; Puzas JE; Schwarz EM
    J Orthop Res; 2002 Mar; 20(2):169-73. PubMed ID: 11918293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.